BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7578149)

  • 1. A peptide derived from a tissue factor loop region functions as a tissue factor--factor VIIa antagonist.
    Paborsky LR; Law VS; Mao CT; Leung LL; Gibbs CS
    Biochemistry; 1995 Nov; 34(46):15328-33. PubMed ID: 7578149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the factor VIIa binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis.
    Gibbs CS; McCurdy SN; Leung LL; Paborsky LR
    Biochemistry; 1994 Nov; 33(47):14003-10. PubMed ID: 7947809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing inhibitor-induced conformational changes along the interface between tissue factor and factor VIIa.
    Osterlund M; Owenius R; Carlsson K; Carlsson U; Persson E; Lindgren M; Freskgård PO; Svensson M
    Biochemistry; 2001 Aug; 40(31):9324-8. PubMed ID: 11478900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors.
    Roberge M; Santell L; Dennis MS; Eigenbrot C; Dwyer MA; Lazarus RA
    Biochemistry; 2001 Aug; 40(32):9522-31. PubMed ID: 11583151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity.
    Sorensen AB; Madsen JJ; Svensson LA; Pedersen AA; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
    J Biol Chem; 2016 Feb; 291(9):4671-83. PubMed ID: 26694616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the factor VIIa binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding.
    Kelley RF; Costas KE; O'Connell MP; Lazarus RA
    Biochemistry; 1995 Aug; 34(33):10383-92. PubMed ID: 7654692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor.
    Petersen LC; Olsen OH; Nielsen LS; Freskgård PO; Persson E
    Protein Sci; 2000 May; 9(5):859-66. PubMed ID: 10850795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel soluble tissue factor variant with an altered factor VIIa binding interface.
    Lee GF; Kelley RF
    J Biol Chem; 1998 Feb; 273(7):4149-54. PubMed ID: 9461610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two sites in the tissue factor extracellular domain mediate the recognition of the ligand factor VIIa.
    Ruf W; Edgington TS
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8430-4. PubMed ID: 1924302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E; Olsen OH
    FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
    Carlsson K; Persson E; Carlsson U; Svensson M
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cofactor function of the N-terminal domain of tissue factor.
    Kittur FS; Manithody C; Morrissey JH; Rezaie AR
    J Biol Chem; 2004 Sep; 279(38):39745-9. PubMed ID: 15252050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor.
    Carlsson K; Freskgård PO; Persson E; Carlsson U; Svensson M
    Eur J Biochem; 2003 Jun; 270(12):2576-82. PubMed ID: 12787023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
    Prasad R; Sen P
    Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Factor Residues That Modulate Magnesium-Dependent Rate Enhancements of the Tissue Factor/Factor VIIa Complex.
    Gajsiewicz JM; Nuzzio KM; Rienstra CM; Morrissey JH
    Biochemistry; 2015 Aug; 54(30):4665-71. PubMed ID: 26169722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.
    Lazarus RA; Olivero AG; Eigenbrot C; Kirchhofer D
    Curr Med Chem; 2004 Sep; 11(17):2275-90. PubMed ID: 15379712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.
    Sorensen AB; Tuneew I; Svensson LA; Persson E; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
    J Biol Chem; 2020 Jan; 295(2):517-528. PubMed ID: 31801825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X.
    Huang Q; Neuenschwander PF; Rezaie AR; Morrissey JH
    J Biol Chem; 1996 Sep; 271(36):21752-7. PubMed ID: 8702971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.